Sign in

    Teresa S. Weber

    Chief Executive Officer, Board Member at Biote Corp
    Board
    Since March 2019
    Age
    70 years
    Education
    Holds an M.S. in Management from Purdue University and a B.S. in Economics from New College Florida.
    Tenure
    Has served as the Chief Executive Officer since March 2019 and held board roles since joining BTMD in June 2018, with the position as Board Member being updated in May 2022.

    Also at Biote Corp

    MEC
    Mary Elizabeth Conlon
    VP, Business Development, General Counsel, Corporate Secretary
    RCP
    Robert C. Peterson
    Chief Financial Officer

    About

    Teresa S. Weber is a seasoned executive known for her significant leadership in the healthcare sector. With extensive experience in managing and growing organizations, she has played a key role in steering her companies through strategic transformations in a rapidly evolving industry.

    In her role as Chief Executive Officer and Board Member at BTMD, she has leveraged her strategic vision and operational expertise to drive innovative initiatives and long-term growth. Her contributions have been central to setting the company’s direction and fostering strong governance practices.

    Prior to her tenure at BTMD, she held critical leadership positions at Amen Clinics, Inc. and Mattioli Weber Consulting, where she gained valuable insights into healthcare management and consulting. Her career reflects a consistent record of achievements, demonstrating her capacity to lead diverse organizations towards success.

    $BTMD Performance Under Teresa S. Weber

    Past Roles

    OrganizationRoleDate RangeDetails
    BioTE Medical Chief Executive Officer March 2019 - May 2022 Held before joining BTMD.
    BioTE Medical Board Member (Board of Managers) June 2018 - May 2022 Held before joining BTMD.
    Amen Clinics, Inc. Chief Executive Officer January 2015 - March 2019 Outpatient healthcare clinic company.
    Mattioli Weber Consulting Partner and Consultant Since June 2013 Marketing, service, and retail consulting firm.

    Fixed Compensation

    Data from  FY 2023
    Component NameAmountPayment ScheduleAdditional Details
    Base Salary$610,000 AnnualCompensation for services rendered as CEO of Biote

    Performance Compensation

    Data from  FY 2023

    Non-Equity Incentive Plan Compensation

    MetricDetails
    ComponentCash-based Performance Bonus
    Dollar Amount$457,125
    Performance Metric2023 Corporate Goals Achievement
    Evaluation Period2023
    Actual Achievement75%
    Calculation BasisPercentage of gross base salary
    Vesting ScheduleNot applicable (cash-based)
    Grant Date / Fair ValueNot applicable
    Additional DetailsNo further details on thresholds, targets, weights, or caps were provided